Carlo Patrono

Università Cattolica del Sacro Cuore — Italy

Medicine · Health Sciences

105h-index66.2kcitations606works3.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Antiplatelet Therapy and Cardiovascular Diseases(211), Inflammatory mediators and NSAID effects(208), Eicosanoids and Hypertension Pharmacology(87), Venous Thromboembolism Diagnosis and Management(66), Atrial Fibrillation Management and Outcomes(44)

Publications601 total

Weekly Journal Scan: In search for the optimal DAPT duration after percutaneous coronary intervention in patients with or without high bleeding risk
European Heart Journal·2025
Platelet activation, aspirin, and cancer: From basic science to clinical trials
Pharmacological Reviews·2025Open Access
Weekly Journal Scan: Navigating the troubled OCEAN of post-ablation antithrombotic management
European Heart Journal·2025
Weekly Journal Scan: Balancing reduced thromboembolic recurrence with enhanced bleeding liability associated with extended low-dose anticoagulation
European Heart Journal·2025
Weekly Journal Scan: Ischaemic vs bleeding risk early after myocardial infarction—which should we TARGET FIRST?
European Heart Journal·2025
Weekly Journal Scan: Rethinking dual antiplatelet therapy after coronary artery bypass grafting for acute coronary syndromes
European Heart Journal·2025
Weekly Journal Scan: spironolactone does not ACHIEVE reduction of cardiovascular outcomes in dialysis patients
European Heart Journal·2025
Weekly Journal Scan: the NEO-MINDSET of early aspirin discontinuation in patients with acute coronary syndromes is neither justified nor safe
European Heart Journal·2025
Aspirin inhibition and recovery of cyclooxygenase activity and thromboxane biosynthesis in human megakaryocytes: a translational surrogate model
Journal of Pharmacology and Experimental Therapeutics·2025Open Access
Estimating the long-term effects of aspirin for primary prevention
European Heart Journal·2025· 2 cited
Weekly Journal Scan: REDEFINing the next generation of obesity pharmacotherapy
European Heart Journal·2025
Weekly Journal Scan: can an individual participant data meta-analysis support a practice change in long-term antiplatelet therapy after percutaneous coronary intervention?
European Heart Journal·2025
Weekly Journal Scan: Angiopoietin-related protein 4 inhibition as a novel approach to atherogenic lipid targeting
European Heart Journal·2025Open Access
Weekly Journal Scan: The ESSENCE of metabolic risk: targeting metabolic dysfunction-associated steatohepatitis with semaglutide
European Heart Journal·2025· 1 cited
Weekly Journal Scan: Extending anticoagulation beyond 6 months after venous thromboembolism in patients with active cancer. Is low-dose apixaban the answer?
European Heart Journal·2025
Weekly Journal Scan: is a SMART-CHOICE of clopidogrel monotherapy after coronary stenting supported by adequate evidence?
European Heart Journal·2025· 2 cited
Weekly Journal Scan: Platelet thromboxane suppression as the mechanism of the anti-metastatic effect of aspirin
European Heart Journal·2025· 2 cited
Weekly Journal Scan: a legacy cardiorenal effect of empagliflozin in patients with chronic kidney disease?
European Heart Journal·2025
Weekly Journal Scan: Is there adequate evidence for targeting only one pathway of platelet activation shortly after an acute coronary syndrome?
European Heart Journal·2025
Weekly Journal Scan: Uncoupling thrombosis from hemostasis in atrial fibrillation? An AZALEA surfing over troubled water
European Heart Journal·2025
page 1 of 31Next →

Frequent Co-authors

Giovanni Ciabattoni(11), Giovanni Davı̀(10), Robert F. Storey(7), Christi Deaton(7), Garret A. FitzGerald(6), Marco Valgimigli(5), Jeroen J. Bax(5), Stephan Windecker(5), Javier Escaned(5), Colin Baigent(5), Bianca Rocca(5), Paola Patrignani(5), Christian Mueller(4), Felicita Andreotti(4), Patrizio Lancellotti(4), David Hasdai(4), Miguel Sousa‐Uva(4), Francesco Cosentino(4), Heikki Huikuri(4), Nikolaus Marx(4)